Immunome IncNASDAQ:IMNM
- LAST PRICE11.2800
- TODAY'S CHANGE (%)1.4600 (14.8676%)
- Bid / Lots11.2500/ 9
- Ask / Lots11.3100/ 3
- Open / Previous Close11.1000 / 9.8200
- Day Range
- 52 Week Range
- Volume1,336,918
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IMNM |
|---|---|---|
| 09:32 ET | 51811 | 11.12 |
| 09:33 ET | 26814 | 10.915 |
| 09:35 ET | 17420 | 11 |
| 09:37 ET | 31663 | 11.192 |
| 09:39 ET | 18057 | 11.125 |
| 09:42 ET | 67507 | 11.12 |
| 09:44 ET | 7238 | 11.1 |
| 09:46 ET | 7556 | 11.135 |
| 09:48 ET | 25090 | 11.165 |
| 09:50 ET | 16028 | 11.05 |
| 09:51 ET | 12713 | 10.98 |
| 09:53 ET | 7247 | 11.05 |
| 09:55 ET | 8840 | 10.91 |
| 09:57 ET | 8543 | 10.89 |
| 10:00 ET | 5736 | 10.89 |
| 10:02 ET | 1478 | 10.955 |
| 10:04 ET | 8017 | 10.87 |
| 10:06 ET | 5605 | 10.905 |
| 10:08 ET | 23164 | 10.98 |
| 10:09 ET | 900 | 10.965 |
| 10:11 ET | 10769 | 10.88 |
| 10:13 ET | 3133 | 10.9 |
| 10:15 ET | 8342 | 10.91 |
| 10:18 ET | 1656 | 10.91 |
| 10:20 ET | 22702 | 11 |
| 10:22 ET | 36298 | 11.04 |
| 10:24 ET | 4506 | 11.09 |
| 10:26 ET | 7365 | 11.085 |
| 10:27 ET | 8381 | 10.9958 |
| 10:29 ET | 7085 | 10.865 |
| 10:31 ET | 2534 | 10.81 |
| 10:33 ET | 1900 | 10.86 |
| 10:36 ET | 4735 | 10.88 |
| 10:38 ET | 4688 | 10.82 |
| 10:40 ET | 1271 | 10.84 |
| 10:42 ET | 6310 | 10.8 |
| 10:44 ET | 3080 | 10.77 |
| 10:45 ET | 3630 | 10.765 |
| 10:47 ET | 4004 | 10.7 |
| 10:49 ET | 7763 | 10.83 |
| 10:51 ET | 4200 | 10.83 |
| 10:54 ET | 1500 | 10.78 |
| 10:56 ET | 7722 | 10.87 |
| 10:58 ET | 2100 | 10.865 |
| 11:00 ET | 2998 | 10.78 |
| 11:02 ET | 3015 | 10.835 |
| 11:03 ET | 2321 | 10.78 |
| 11:05 ET | 2000 | 10.86 |
| 11:07 ET | 3309 | 10.84 |
| 11:09 ET | 1100 | 10.835 |
| 11:12 ET | 2861 | 10.81 |
| 11:14 ET | 8228 | 10.78 |
| 11:16 ET | 1100 | 10.745 |
| 11:18 ET | 4991 | 10.78 |
| 11:20 ET | 2657 | 10.76 |
| 11:21 ET | 1372 | 10.77 |
| 11:23 ET | 6247 | 10.785 |
| 11:25 ET | 2162 | 10.835 |
| 11:27 ET | 1482 | 10.845 |
| 11:30 ET | 1619 | 10.85 |
| 11:32 ET | 2700 | 10.855 |
| 11:34 ET | 6614 | 10.9 |
| 11:36 ET | 8500 | 10.905 |
| 11:38 ET | 1800 | 10.92 |
| 11:39 ET | 800 | 10.92 |
| 11:41 ET | 2497 | 10.955 |
| 11:43 ET | 2457 | 10.935 |
| 11:45 ET | 2100 | 10.865 |
| 11:48 ET | 17973 | 10.86 |
| 11:50 ET | 1005 | 10.85 |
| 11:52 ET | 600 | 10.84 |
| 11:54 ET | 1400 | 10.835 |
| 11:56 ET | 5780 | 10.86 |
| 11:57 ET | 2113 | 10.88 |
| 11:59 ET | 2335 | 10.87 |
| 12:01 ET | 3666 | 10.935 |
| 12:03 ET | 13317 | 10.915 |
| 12:06 ET | 9210 | 10.93 |
| 12:08 ET | 375 | 10.91 |
| 12:10 ET | 200 | 10.91 |
| 12:12 ET | 6451 | 10.84 |
| 12:14 ET | 600 | 10.83 |
| 12:15 ET | 1737 | 10.805 |
| 12:17 ET | 6601 | 10.785 |
| 12:19 ET | 1443 | 10.76 |
| 12:21 ET | 2807 | 10.765 |
| 12:24 ET | 4151 | 10.755 |
| 12:26 ET | 900 | 10.755 |
| 12:28 ET | 700 | 10.755 |
| 12:30 ET | 14774 | 10.7 |
| 12:32 ET | 2023 | 10.685 |
| 12:33 ET | 7596 | 10.8 |
| 12:35 ET | 100 | 10.8 |
| 12:37 ET | 300 | 10.81 |
| 12:39 ET | 4708 | 10.85 |
| 12:42 ET | 1521 | 10.84 |
| 12:44 ET | 17537 | 10.835 |
| 12:46 ET | 800 | 10.835 |
| 12:48 ET | 1821 | 10.8 |
| 12:50 ET | 1060 | 10.795 |
| 12:51 ET | 1525 | 10.81 |
| 12:53 ET | 3708 | 10.84 |
| 12:55 ET | 500 | 10.86 |
| 12:57 ET | 6243 | 10.85 |
| 01:00 ET | 2580 | 10.93 |
| 01:02 ET | 5400 | 10.95 |
| 01:04 ET | 300 | 10.95 |
| 01:06 ET | 1363 | 10.98 |
| 01:08 ET | 11283 | 11.04 |
| 01:09 ET | 300 | 11.04 |
| 01:11 ET | 7453 | 11.11 |
| 01:13 ET | 3300 | 11.105 |
| 01:15 ET | 900 | 11.12 |
| 01:18 ET | 7851 | 11.12 |
| 01:20 ET | 2943 | 11.075 |
| 01:22 ET | 1975 | 11.07 |
| 01:24 ET | 2500 | 11.095 |
| 01:26 ET | 4221 | 11.095 |
| 01:27 ET | 800 | 11.095 |
| 01:29 ET | 1692 | 11.095 |
| 01:31 ET | 1151 | 11.095 |
| 01:33 ET | 7836 | 11.155 |
| 01:36 ET | 692 | 11.17 |
| 01:40 ET | 4372 | 11.145 |
| 01:42 ET | 1800 | 11.12 |
| 01:44 ET | 500 | 11.115 |
| 01:45 ET | 1100 | 11.115 |
| 01:47 ET | 3892 | 11.065 |
| 01:49 ET | 1456 | 10.97 |
| 01:51 ET | 1325 | 10.91 |
| 01:54 ET | 2116 | 10.88 |
| 01:56 ET | 1966 | 10.915 |
| 01:58 ET | 5618 | 10.94 |
| 02:00 ET | 4480 | 10.965 |
| 02:02 ET | 700 | 10.98 |
| 02:03 ET | 4103 | 10.97 |
| 02:05 ET | 1915 | 10.97 |
| 02:07 ET | 9852 | 11.06 |
| 02:09 ET | 14410 | 11.085 |
| 02:12 ET | 1212 | 11.085 |
| 02:14 ET | 30123 | 11.195 |
| 02:16 ET | 6000 | 11.195 |
| 02:18 ET | 600 | 11.195 |
| 02:20 ET | 1347 | 11.175 |
| 02:21 ET | 2300 | 11.185 |
| 02:23 ET | 2563 | 11.135 |
| 02:25 ET | 8098 | 11.09 |
| 02:27 ET | 102611 | 11.105 |
| 02:30 ET | 1100 | 11.1 |
| 02:32 ET | 8812 | 11.11 |
| 02:34 ET | 1600 | 11.11 |
| 02:36 ET | 2599 | 11.11 |
| 02:38 ET | 1900 | 11.12 |
| 02:39 ET | 1100 | 11.125 |
| 02:41 ET | 1485 | 11.12 |
| 02:43 ET | 5691 | 11.21 |
| 02:45 ET | 3831 | 11.29 |
| 02:48 ET | 2845 | 11.3 |
| 02:50 ET | 700 | 11.28 |
Nov 14, 2024
DJ Immunome Is Maintained at Overweight by Piper Sandler, from 7:35AM ET on Thursday Nov 14, 2024 by Dow Jones
7:35AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones*DJ Immunome 3Q Loss/Shr 78c >IMNM, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 8, 2024
DJ Immunome Initiated at Overweight by Stephens & Co., from 7:16AM ET on Friday Nov 08, 2024 by Dow Jones
7:16AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 5, 2024
Immunome to Present at Guggenheim's Inaugural Healthcare Innovation Conference, from 8:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Immunome Inc | 611.6M | -1.9x | --- |
Stoke Therapeutics Inc | 605.4M | -5.8x | --- |
Mereo BioPharma Group PLC | 572.3M | 0.0x | --- |
SS Innovations International Inc | 631.7M | -22.6x | --- |
Arbutus Biopharma Corp | 665.1M | -8.2x | --- |
Altimmune Inc | 616.9M | -5.6x | --- |
Company Information
Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company's portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, radioligand therapies and Antibody-Drug Conjugates (ADCs). Its memory B cell hybridoma technology allows for the screening and functional characterization of novel antibodies and targets. Its programs include Oncology (IMM-ONC-01), LU FAP, and SARS-CoV-2 (IMM-BCP-01). The oncology program is an antibody (IMM-ONC-01) against interleukin-38 (IL-38) a novel immune modulator for the treatment of various solid tumors. Its Targeted Effector platform uses small molecule ligands to selectively deliver drug payloads to diseased cells. It also operates AL102 and related drug candidate AL101. AL102 is an investigational small molecule gamma secretase inhibitor being evaluated in the Phase III for the treatment of desmoid tumors. AL102 is a potential once-daily oral treatment for desmoid tumors.
Contact Information
- Headquarters
- 18702 N. CREEK PARKWAY, SUITE 100BOTHELL, WA, United States 98011
- Phone
- 610-321-3700
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Clay Siegall
- Chief Financial Officer, Executive Vice President - Operations, Principal Accounting Officer, Principal Financial officer
- Max Rosett
- Executive Vice President - Commercial
- Roee Shahar
- Chief Technical Officer
- Phil Tsai
- Chief Scientific Officer
- Jack Higgins
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $611.6M |
|---|---|
Revenue (TTM) | $10.1M |
Shares Outstanding | 62.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.74 |
EPS | $-6.06 |
Book Value | $2.77 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 60.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,134.40% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
